Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3Ovarian Neoplasms 3Carcinoma, Ovarian Epithelial 3Salivary Gland Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Anus Neoplasms 2Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Sezary Syndrome 1Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Penile Neoplasms 1Pelvic Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms, Squamous Cell 1Neoplasms 1Myeloproliferative Disorders 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Leukemia, Prolymphocytic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Acute 1

Interventions

Doxorubicin 5Ifosfamide 3Filgrastim 3belinostat 2Nivolumab 2Imatinib Mesylate 2Gemcitabine 2Docetaxel 2selinexor 1saracatinib 1rucaparib 1perifosine 1pembrolizumab 1brostallicin 1Vorinostat 1Trabectedin 1Therapeutics 1Temozolomide 1Sunitinib 1Radiotherapy 1Radiation, Ionizing 1Mass Spectrometry 1Letrozole 1Injections 1Fluorouracil 1Chromatography, High Pressure Liquid 1Chemotherapy, Adjuvant 1BI 2536 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leiomyosarcoma × Vorinostat × Gynecologic × Clear all
NCT03509207 2020-08-04

Vorinostat (SAHA) in Uterine Sarcoma

Medical University of Graz

Phase 2 Terminated
3 enrolled 6 charts
GynecologicSarcoma

Leiomyosarcoma, Endometrial Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡